At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 20 enrolled
Drug / intervention
Cordis Neurovascular ENTERPRISE Self Expanding Stent System +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Feasibility Study of the Cordis Neurovascular Self Expanding Stent System in Intracranial Arteries
In Brief
A Phase 1 clinical trial evaluating Cordis Neurovascular ENTERPRISE Self Expanding Stent System for Atherosclerosis and Aneurysm. Completed, enrolled 20 participants across 1 site.
Detailed Summary
Feasibility study to assess safety of treating patients with self expanding stent in intracranial arteries.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtherosclerosis, Aneurysm
CountriesArgentina
Collaborators--
Timeline
Phase 1CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 2006
Enrollment StartSep 2006
Primary CompletionOct 2008
Study CompletionMar 2009
TodayJul 2026
First PostedJul 10, 2006
Enrollment StartSep 1, 2006
Primary CompletionOct 1, 2008
Study CompletionMar 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 20.0 years ago
Interventions
Cordis Neurovascular ENTERPRISE Self Expanding Stent Systemdevice
Implantation of the device ENTERPRISE used to treat symptomatic stenosis in intracranial arteries.
Cordis Neurovascular ENTERPRISE Self Expanding Stent Systemdevice
Implantation of the device ENTERPRISE to treat wide-necked aneurysms